Healthcare Sector Stocks
The Healthcare sector has a total of 1044 stocks, with a combined market cap of $8.94 trillion, total revenue of $4.6 trillion and a weighted average PE ratio of 50.08.
Market Cap
8.94T
Revenue
4.6T
Profits
178.51B
PE Ratio
50.08
Profit Margin
3.88%
Dividend Yield
0.38%
1044 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.03T | -1.64% | 2,156,321 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 648.67B | -0.01% | 6,636,661 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 468.43B | -0.05% | 3,469,206 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 365.34B | -1.88% | 9,703,453 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 333.27B | -0.45% | 3,862,805 | 450.53B |
| 6 | NVS | Novartis AG | 270.93B | 1.01% | 2,518,383 | 56.69B |
| 7 | TMO | Thermo Fisher Scientific Inc. | 245.99B | 1.03% | 2,345,631 | 46.34B |
| 8 | AMGN | Amgen Inc. | 219.55B | -1.01% | 2,822,776 | 38.10B |
| 9 | GILD | Gilead Sciences, Inc. | 187.69B | -0.85% | 6,191,680 | 30.46B |
| 10 | ABT | Abbott Laboratories | 179.08B | -0.19% | 12,183,977 | 46.59B |
| 11 | NVO | Novo Nordisk A/S | 170.00B | -3.12% | 18,433,127 | 50.34B |
| 12 | PFE | Pfizer Inc. | 160.62B | 0.90% | 33,812,865 | 63.70B |
| 13 | DHR | Danaher Corporation | 155.75B | 0.21% | 3,404,584 | 25.11B |
| 14 | ISRG | Intuitive Surgical, Inc. | 140.71B | -0.94% | 1,686,476 | 11.03B |
| 15 | VRTX | Vertex Pharmaceuticals Incorporated | 130.87B | 0.26% | 1,214,099 | 12.59B |
| 16 | BMY | Bristol-Myers Squibb Company | 124.91B | -1.77% | 15,843,162 | 49.19B |
| 17 | MDT | Medtronic plc | 114.23B | -1.62% | 10,534,180 | 37.54B |
| 18 | CVS | CVS Health Corporation | 109.81B | -1.42% | 7,315,534 | 412.65B |
| 19 | SYK | Stryker Corporation | 104.87B | -0.61% | 2,722,054 | 25.84B |
| 20 | MCK | McKesson Corporation | 102.66B | -1.20% | 672,913 | 410.98B |
| 21 | GSK | GSK plc | 100.19B | -1.99% | 3,040,786 | 44.05B |
| 22 | SNY | Sanofi | 99.80B | -2.00% | 3,838,023 | 55.89B |
| 23 | HCA | HCA Healthcare, Inc. | 94.50B | -0.37% | 1,314,007 | 78.01B |
| 24 | ELV | Elevance Health, Inc. | 86.44B | -0.96% | 1,207,567 | 201.11B |
| 25 | REGN | Regeneron Pharmaceuticals, Inc. | 80.07B | -0.26% | 721,111 | 15.53B |
| 26 | MRNA | Moderna, Inc. | 72.70B | -0.25% | 17,738,524 | 2.23B |
| 27 | CI | The Cigna Group | 70.89B | -2.00% | 1,829,725 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 64.66B | -0.67% | 18,592,872 | 21.00B |
| 29 | TAK | Takeda Pharmaceutical Company Limited | 60.71B | -0.74% | 2,606,362 | 28.42B |
| 30 | COR | Cencora, Inc. | 59.59B | -0.68% | 1,103,060 | 332.77B |
| 31 | ARGX | argenx SE | 59.55B | -1.86% | 426,478 | 5.32B |
| 32 | NTRA | Natera, Inc. | 56.33B | -0.03% | 1,690,565 | 2.71B |
| 33 | CAH | Cardinal Health, Inc. | 51.24B | -0.35% | 1,215,981 | 254.25B |
| 34 | EW | Edwards Lifesciences Corporation | 50.04B | -2.21% | 3,623,733 | 6.51B |
| 35 | BDX | Becton, Dickinson and Company | 49.72B | -0.26% | 1,022,795 | 22.48B |
| 36 | A | Agilent Technologies, Inc. | 46.61B | -1.16% | 3,238,623 | 7.37B |
| 37 | TEVA | Teva Pharmaceutical Industries Limited | 45.46B | -1.29% | 6,138,695 | 17.32B |
| 38 | MDLN | Medline Inc. | 45.09B | -0.38% | 8,592,732 | 29.94B |
| 39 | HUM | Humana Inc. | 45.00B | 0.75% | 798,633 | 145.68B |
| 40 | IQV | IQVIA Holdings Inc. | 44.09B | -0.83% | 1,116,576 | 16.98B |
| 41 | VEEV | Veeva Systems Inc. | 43.84B | 3.77% | 1,427,173 | 3.46B |
| 42 | ONC | BeOne Medicines AG | 41.50B | -0.84% | 631,810 | 6.13B |
| 43 | WAT | Waters Corporation | 41.32B | -1.21% | 743,554 | 4.64B |
| 44 | IDXX | IDEXX Laboratories, Inc. | 41.13B | 0.10% | 364,187 | 4.55B |
| 45 | RVMD | Revolution Medicines, Inc. | 40.88B | -1.10% | 2,124,779 | - |
| 46 | HLN | Haleon plc | 39.89B | -1.51% | 21,338,640 | 14.80B |
| 47 | ILMN | Illumina, Inc. | 38.56B | 3.20% | 2,300,938 | 4.49B |
| 48 | BIIB | Biogen Inc. | 33.62B | 0.96% | 1,494,452 | 10.03B |
| 49 | RPRX | Royalty Pharma plc | 33.15B | -1.49% | 2,804,333 | 2.54B |
| 50 | DXCM | DexCom, Inc. | 33.11B | -2.01% | 3,701,755 | 4.97B |
| 51 | ALNY | Alnylam Pharmaceuticals, Inc. | 32.99B | -2.04% | 1,480,415 | 4.80B |
| 52 | RMD | ResMed Inc. | 31.80B | 0.15% | 1,440,113 | 5.65B |
| 53 | ALC | Alcon Inc. | 31.65B | -0.30% | 1,053,960 | 10.86B |
| 54 | CNC | Centene Corporation | 30.67B | -1.93% | 3,417,986 | 180.30B |
| 55 | MTD | Mettler-Toledo International Inc. | 29.90B | 0.11% | 238,567 | 4.13B |
| 56 | GEHC | GE HealthCare Technologies Inc. | 29.85B | -0.27% | 3,169,507 | 21.27B |
| 57 | ZTS | Zoetis Inc. | 29.59B | -1.72% | 3,845,531 | 9.53B |
| 58 | ROIV | Roivant Sciences Ltd. | 26.60B | -3.66% | 9,272,902 | 7.53M |
| 59 | WST | West Pharmaceutical Services, Inc. | 26.45B | 1.29% | 876,924 | 3.33B |
| 60 | INSM | Insmed Incorporated | 25.84B | -2.05% | 1,921,593 | 1.14B |
| 61 | DGX | Quest Diagnostics Incorporated | 25.72B | -0.75% | 1,129,616 | 11.56B |
| 62 | INCY | Incyte Corporation | 25.26B | -1.80% | 1,534,326 | 5.82B |
| 63 | BNTX | BioNTech SE | 24.73B | -2.39% | 1,087,530 | 3.03B |
| 64 | LH | Labcorp Holdings Inc. | 24.65B | -2.43% | 909,589 | 14.35B |
| 65 | PHG | Koninklijke Philips N.V. | 24.09B | -2.08% | 747,827 | 20.18B |
| 66 | GH | Guardant Health, Inc. | 23.66B | -0.48% | 1,432,141 | 1.18B |
| 67 | UTHR | United Therapeutics Corporation | 20.99B | -1.64% | 433,387 | 3.15B |
| 68 | GMAB | Genmab A/S | 20.87B | -1.33% | 2,509,744 | 4.13B |
| 69 | THC | Tenet Healthcare Corporation | 20.65B | -2.14% | 632,243 | 21.81B |
| 70 | STE | STERIS plc | 20.47B | 0.57% | 534,049 | 6.04B |
| 71 | VTRS | Viatris Inc. | 19.66B | -0.35% | 6,876,451 | 14.74B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 17.33B | -3.30% | 2,974,306 | 8.51B |
| 73 | MEDP | Medpace Holdings, Inc. | 17.23B | -2.07% | 275,740 | 2.78B |
| 74 | RVTY | Revvity, Inc. | 15.86B | -0.84% | 2,244,120 | 2.91B |
| 75 | JAZZ | Jazz Pharmaceuticals plc | 15.25B | -2.37% | 792,218 | 4.60B |
| 76 | SOLV | Solventum Corporation | 15.04B | -0.43% | 860,084 | 8.31B |
| 77 | ASND | Ascendis Pharma A/S | 14.65B | -6.08% | 1,218,240 | 1.20B |
| 78 | NBIX | Neurocrine Biosciences, Inc. | 14.18B | -1.94% | 1,747,907 | 3.37B |
| 79 | EXEL | Exelixis, Inc. | 14.06B | -2.44% | 1,431,532 | 2.44B |
| 80 | TEM | Tempus AI, Inc. | 13.82B | -0.78% | 5,375,412 | 1.43B |
| 81 | CRL | Charles River Laboratories International, Inc. | 13.24B | -2.73% | 1,594,221 | 4.00B |
| 82 | SMMT | Summit Therapeutics Inc. | 13.12B | -3.91% | 3,891,054 | - |
| 83 | BBIO | BridgeBio Pharma, Inc. | 12.85B | -5.08% | 3,677,553 | 713.07M |
| 84 | HALO | Halozyme Therapeutics, Inc. | 12.76B | -2.34% | 2,702,713 | 1.66B |
| 85 | ICLR | ICON Public Limited Company | 12.65B | -1.92% | 1,064,824 | 8.29B |
| 86 | PEN | Penumbra, Inc. | 12.58B | 0.02% | 410,633 | 1.50B |
| 87 | CORT | Corcept Therapeutics Incorporated | 12.21B | -3.89% | 809,840 | 830.81M |
| 88 | BAX | Baxter International Inc. | 12.14B | -0.80% | 9,441,690 | 11.47B |
| 89 | EHC | Encompass Health Corporation | 12.06B | -0.45% | 954,427 | 6.21B |
| 90 | BMRN | BioMarin Pharmaceutical Inc. | 12.04B | -1.83% | 2,105,163 | 3.41B |
| 91 | FMS | Fresenius Medical Care AG | 11.96B | -0.40% | 735,435 | 22.19B |
| 92 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.85B | -1.12% | 315,951 | 1.28B |
| 93 | DVA | DaVita Inc. | 11.68B | -0.32% | 544,275 | 14.01B |
| 94 | BTSG | BrightSpring Health Services, Inc. | 11.62B | -1.36% | 1,726,009 | 14.37B |
| 95 | TECH | Bio-Techne Corporation | 11.37B | -0.04% | 3,562,210 | 1.22B |
| 96 | ELAN | Elanco Animal Health Incorporated | 11.28B | -1.57% | 5,336,481 | 5.02B |
| 97 | SNN | Smith & Nephew plc | 11.24B | -2.47% | 1,794,061 | 6.30B |
| 98 | UHS | Universal Health Services, Inc. | 10.69B | 1.17% | 896,203 | 18.11B |
| 99 | COO | The Cooper Companies, Inc. | 10.66B | 1.41% | 4,136,331 | 4.24B |
| 100 | ALGN | Align Technology, Inc. | 10.53B | -3.34% | 1,327,020 | 4.14B |
| 101 | RDY | Dr. Reddy's Laboratories Limited | 10.52B | -1.43% | 2,485,104 | 3.50B |
| 102 | RGEN | Repligen Corporation | 10.41B | -1.19% | 934,688 | 785.10M |
| 103 | ENSG | The Ensign Group, Inc. | 10.14B | -0.49% | 341,152 | 5.49B |
| 104 | AXSM | Axsome Therapeutics, Inc. | 10.13B | -4.75% | 912,948 | 776.57M |
| 105 | BIO | Bio-Rad Laboratories, Inc. | 10.13B | -0.18% | 177,213 | 2.59B |
| 106 | KRYS | Krystal Biotech, Inc. | 10.12B | -2.60% | 215,939 | 440.48M |
| 107 | AVTR | Avantor, Inc. | 9.98B | -1.20% | 10,569,278 | 6.56B |
| 108 | TWST | Twist Bioscience Corporation | 9.94B | -3.71% | 2,133,731 | 431.80M |
| 109 | GMED | Globus Medical, Inc. | 9.93B | -1.64% | 1,456,766 | 3.14B |
| 110 | MOH | Molina Healthcare, Inc. | 9.86B | -0.95% | 647,541 | 42.47B |
| 111 | TXG | 10x Genomics, Inc. | 9.85B | -6.29% | 3,476,541 | 616.91M |
| 112 | KYMR | Kymera Therapeutics, Inc. | 9.60B | -5.40% | 969,613 | 105.00M |
| 113 | HSIC | Henry Schein, Inc. | 9.48B | -2.72% | 1,119,558 | 13.60B |
| 114 | PODD | Insulet Corporation | 9.47B | -2.07% | 1,021,303 | 3.05B |
| 115 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.46B | -6.82% | 2,555,515 | 669.50M |
| 116 | OSCR | Oscar Health, Inc. | 9.41B | -0.46% | 5,526,946 | 15.32B |
| 117 | CYTK | Cytokinetics, Incorporated | 9.15B | -2.63% | 2,034,372 | 67.67M |
| 118 | IBRX | ImmunityBio, Inc. | 9.15B | -7.10% | 13,954,480 | 165.79M |
| 119 | BRKR | Bruker Corporation | 9.09B | -2.52% | 2,498,595 | 3.50B |
| 120 | GKOS | Glaukos Corporation | 9.05B | -3.98% | 1,026,713 | 612.84M |
| 121 | QGEN | Qiagen N.V. | 9.04B | 0.05% | 3,034,963 | 2.10B |
| 122 | PTGX | Protagonist Therapeutics, Inc. | 8.98B | -4.39% | 513,167 | 281.99M |
| 123 | CAI | Caris Life Sciences, Inc. | 8.94B | 0.57% | 4,359,805 | 989.61M |
| 124 | PCVX | Vaxcyte, Inc. | 8.41B | -4.28% | 1,650,387 | - |
| 125 | ABVX | ABIVAX Société Anonyme | 8.32B | -4.23% | 2,637,351 | 5.33M |
| 126 | TGTX | TG Therapeutics, Inc. | 7.94B | -3.63% | 2,119,981 | 799.54M |
| 127 | ATR | AptarGroup, Inc. | 7.93B | -0.57% | 335,320 | 3.93B |
| 128 | PRAX | Praxis Precision Medicines, Inc. | 7.88B | -6.16% | 1,005,258 | 7.46M |
| 129 | SYRE | Spyre Therapeutics, Inc. | 7.77B | -4.13% | 918,763 | - |
| 130 | HQY | HealthEquity, Inc. | 7.48B | -1.48% | 900,129 | 1.36B |
| 131 | HNGE | Hinge Health, Inc. | 7.45B | -1.99% | 1,702,830 | 720.06M |
| 132 | IONS | Ionis Pharmaceuticals, Inc. | 7.30B | -3.98% | 3,535,505 | 874.09M |
| 133 | IMVT | Immunovant, Inc. | 7.13B | -7.37% | 3,652,686 | - |
| 134 | ALKS | Alkermes plc | 7.07B | -2.68% | 2,475,683 | 1.67B |
| 135 | BLTE | Belite Bio, Inc | 6.79B | -3.81% | 153,823 | - |
| 136 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.76B | -1.04% | 683,853 | 239.92M |
| 137 | AMRX | Amneal Pharmaceuticals, Inc. | 6.73B | -0.87% | 3,575,411 | 3.12B |
| 138 | HIMS | Hims & Hers Health, Inc. | 6.62B | -6.70% | 11,886,214 | 2.58B |
| 139 | LNTH | Lantheus Holdings, Inc. | 6.53B | -0.01% | 865,428 | 1.56B |
| 140 | CGON | CG Oncology, Inc. | 6.50B | -5.63% | 830,945 | 6.23M |
| 141 | PACS | PACS Group, Inc. | 6.50B | -1.16% | 531,177 | 5.55B |
| 142 | CHE | Chemed Corporation | 6.48B | 0.30% | 138,535 | 2.60B |
| 143 | GRFS | Grifols, S.A. | 6.39B | -3.29% | 4,065,084 | 8.48B |
| 144 | BLCO | Bausch + Lomb Corporation | 6.09B | -1.56% | 299,086 | 5.32B |
| 145 | SRRK | Scholar Rock Holding Corporation | 6.07B | -2.62% | 2,492,616 | - |
| 146 | LQDA | Liquidia Corporation | 6.04B | -1.68% | 766,135 | 450.91M |
| 147 | ORKA | Oruka Therapeutics, Inc. | 5.95B | -4.89% | 1,992,962 | - |
| 148 | LGND | Ligand Pharmaceuticals Incorporated | 5.95B | -0.03% | 241,150 | 290.54M |
| 149 | KNSA | Kiniksa Pharmaceuticals International, plc | 5.94B | -2.46% | 408,261 | 840.85M |
| 150 | STVN | Stevanato Group S.p.A. | 5.92B | -0.05% | 205,776 | 1.40B |
| 151 | MIRM | Mirum Pharmaceuticals, Inc. | 5.80B | -2.27% | 739,007 | 618.07M |
| 152 | MMED | MiniMed Group, Inc. | 5.78B | -3.11% | 2,845,282 | 3.22B |
| 153 | RDNT | RadNet, Inc. | 5.76B | -1.04% | 560,678 | 2.27B |
| 154 | TVTX | Travere Therapeutics, Inc. | 5.64B | -0.75% | 1,713,828 | 591.33M |
| 155 | COGT | Cogent Biosciences, Inc. | 5.45B | -3.74% | 2,330,471 | - |
| 156 | BLLN | BillionToOne, Inc. | 5.40B | -1.42% | 397,671 | 397.41M |
| 157 | CRSP | CRISPR Therapeutics AG | 5.39B | -5.54% | 2,362,270 | 13.39M |
| 158 | DNTH | Dianthus Therapeutics, Inc. | 5.22B | -5.04% | 1,187,392 | 1.90M |
| 159 | SHC | Sotera Health Company | 5.22B | -2.14% | 1,758,474 | 1.22B |
| 160 | PTCT | PTC Therapeutics, Inc. | 5.20B | -5.49% | 1,101,126 | 1.01B |
| 161 | MMSI | Merit Medical Systems, Inc. | 5.20B | -0.22% | 611,306 | 1.58B |
| 162 | TFX | Teleflex Incorporated | 5.16B | -2.52% | 832,627 | 2.25B |
| 163 | DFTX | Definium Therapeutics, Inc. | 5.06B | -6.62% | 2,712,179 | - |
| 164 | GRAL | GRAIL, Inc. | 4.90B | 1.12% | - | 165.26M |
| 165 | ERAS | Erasca, Inc. | 4.88B | -10.32% | 4,424,039 | - |
| 166 | HAE | Haemonetics Corporation | 4.86B | -1.57% | 704,928 | 1.35B |
| 167 | VKTX | Viking Therapeutics, Inc. | 4.86B | 1.96% | 15,730,305 | - |
| 168 | MANE | Veradermics, Incorporated | 4.84B | -2.00% | 754,267 | - |
| 169 | WAY | Waystar Holding Corp. | 4.75B | -3.39% | 1,496,391 | 1.21B |
| 170 | DOCS | Doximity, Inc. | 4.74B | 0.23% | 2,474,530 | 655.57M |
| 171 | LFST | LifeStance Health Group, Inc. | 4.62B | -3.71% | 7,615,125 | 1.58B |
| 172 | IOVA | Iovance Biotherapeutics, Inc. | 4.62B | -4.23% | 15,916,497 | 324.97M |
| 173 | EWTX | Edgewise Therapeutics, Inc. | 4.46B | -7.77% | 2,607,020 | - |
| 174 | ADPT | Adaptive Biotechnologies Corporation | 4.45B | -0.61% | 1,079,839 | 308.08M |
| 175 | CON | Concentra Group Holdings Parent, Inc. | 4.44B | -0.26% | 815,537 | 2.29B |
| 176 | ACAD | ACADIA Pharmaceuticals Inc. | 4.38B | -3.71% | 1,306,192 | 1.14B |
| 177 | ITGR | Integer Holdings Corporation | 4.29B | -0.01% | 527,946 | 1.84B |
| 178 | LIVN | LivaNova PLC | 4.25B | -1.62% | 493,111 | 1.47B |
| 179 | TNGX | Tango Therapeutics, Inc. | 4.12B | -4.23% | 4,957,082 | 53.81M |
| 180 | HTFL | HeartFlow, Inc. | 4.12B | -5.54% | 2,099,349 | 212.07M |
| 181 | PBLS | Parabilis Medicines, Inc. | 4.11B | -12.73% | 1,113,850 | 148.00K |
| 182 | ICUI | ICU Medical, Inc. | 4.08B | 1.45% | 408,285 | 2.16B |
| 183 | ABCL | AbCellera Biologics Inc. | 3.99B | -2.69% | 3,850,701 | 66.17M |
| 184 | RLAY | Relay Therapeutics, Inc. | 3.95B | -6.82% | 4,708,795 | 10.35M |
| 185 | CELC | Celcuity Inc. | 3.91B | -4.89% | 739,442 | - |
| 186 | TLX | Telix Pharmaceuticals Limited | 3.85B | -5.69% | 464,893 | 890.79M |
| 187 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.84B | -7.26% | 1,824,751 | -665.00K |
| 188 | NVST | Envista Holdings Corporation | 3.83B | -1.49% | 2,410,888 | 2.86B |
| 189 | PLSE | Pulse Biosciences, Inc. | 3.71B | -1.35% | 550,582 | 1.19M |
| 190 | IRTC | iRhythm Holdings, Inc. | 3.68B | 1.10% | 1,225,930 | 825.34M |
| 191 | IDYA | IDEAYA Biosciences, Inc. | 3.61B | -5.67% | 2,238,178 | 234.13M |
| 192 | OGN | Organon & Co. | 3.61B | 0.22% | 983,339 | 6.13B |
| 193 | LEGN | Legend Biotech Corporation | 3.58B | -1.02% | 2,409,400 | 1.27B |
| 194 | XENE | Xenon Pharmaceuticals Inc. | 3.54B | -6.47% | 3,173,816 | 7.50M |
| 195 | VCYT | Veracyte, Inc. | 3.52B | 1.06% | 1,525,526 | 561.90M |
| 196 | NHC | National HealthCare Corporation | 3.52B | 0.90% | 113,769 | 1.56B |
| 197 | OPCH | Option Care Health, Inc. | 3.50B | -2.34% | 1,330,584 | 5.69B |
| 198 | ELVN | Enliven Therapeutics, Inc. | 3.38B | -4.32% | 1,550,883 | - |
| 199 | RCUS | Arcus Biosciences, Inc. | 3.36B | -1.79% | 1,561,368 | 117.00M |
| 200 | ARQT | Arcutis Biotherapeutics, Inc. | 3.32B | -5.04% | 2,512,179 | 463.98M |
| 201 | DNLI | Denali Therapeutics Inc. | 3.27B | -5.28% | 1,914,034 | 3.60M |
| 202 | TARS | Tarsus Pharmaceuticals, Inc. | 3.26B | -3.62% | 674,306 | 606.33M |
| 203 | ATRC | AtriCure, Inc. | 3.05B | 1.91% | 1,206,222 | 569.62M |
| 204 | DYN | Dyne Therapeutics, Inc. | 3.03B | -5.31% | 2,636,204 | - |
| 205 | TMDX | TransMedics Group, Inc. | 3.02B | -1.21% | 615,584 | 668.47M |
| 206 | ZLAB | Zai Lab Limited | 2.97B | 0.15% | 791,634 | 449.61M |
| 207 | QURE | uniQure N.V. | 2.97B | -5.57% | 1,173,506 | 18.67M |
| 208 | RGC | Regencell Bioscience Holdings Limited | 2.96B | -4.01% | 134,342 | - |
| 209 | NEOG | Neogen Corporation | 2.96B | -2.93% | 3,677,051 | 870.40M |
| 210 | WRBY | Warby Parker Inc. | 2.89B | 1.79% | 2,815,402 | 911.61M |
| 211 | CDNA | CareDx, Inc. | 2.81B | -3.86% | 1,906,170 | 458.09M |
| 212 | AVAH | Aveanna Healthcare Holdings Inc. | 2.79B | -3.25% | 2,426,719 | 2.60B |
| 213 | MBX | MBX Biosciences, Inc. | 2.79B | -6.60% | 352,403 | - |
| 214 | IMNM | Immunome, Inc. | 2.75B | -5.86% | 2,270,639 | 4.02M |
| 215 | GRDN | Guardian Pharmacy Services, Inc. | 2.74B | -3.16% | 440,770 | 1.46B |
| 216 | NAMS | NewAmsterdam Pharma Company N.V. | 2.71B | -2.74% | 2,265,263 | 7.12M |
| 217 | BKD | Brookdale Senior Living Inc. | 2.67B | -1.93% | 2,513,049 | 2.93B |
| 218 | PGEN | Precigen, Inc. | 2.66B | -5.70% | 5,563,947 | 85.72M |
| 219 | ACHC | Acadia Healthcare Company, Inc. | 2.65B | -2.93% | 2,464,874 | 3.37B |
| 220 | GPCR | Structure Therapeutics Inc. | 2.56B | -2.60% | 1,400,749 | - |
| 221 | AXGN | Axogen, Inc. | 2.54B | -2.74% | 1,247,193 | 251.17M |
| 222 | WGS | GeneDx Holdings Corp. | 2.54B | -6.17% | 1,045,717 | 454.43M |
| 223 | IRON | Disc Medicine, Inc. | 2.54B | -3.49% | 541,829 | - |
| 224 | SUPN | Supernus Pharmaceuticals, Inc. | 2.52B | -0.82% | 544,530 | 830.44M |
| 225 | HCM | HUTCHMED (China) Limited | 2.50B | 2.13% | 117,589 | 549.12M |
| 226 | NRIX | Nurix Therapeutics, Inc. | 2.48B | -6.97% | 1,363,970 | 36.77M |
| 227 | BFLY | Butterfly Network, Inc. | 2.45B | -7.35% | 7,793,016 | 112.14M |
| 228 | CLDX | Celldex Therapeutics, Inc. | 2.44B | -7.13% | 4,235,618 | 158.00K |
| 229 | PRVA | Privia Health Group, Inc. | 2.44B | -1.85% | 980,206 | 2.36B |
| 230 | BEAM | Beam Therapeutics Inc. | 2.44B | -6.02% | 1,898,569 | 156.04M |
| 231 | VRDN | Viridian Therapeutics, Inc. | 2.43B | -3.12% | 2,857,644 | 71.13M |
| 232 | CLOV | Clover Health Investments, Corp. | 2.43B | -2.14% | 3,337,575 | 2.48B |
| 233 | TRLV | Trulieve Cannabis Corp. | 2.41B | 0.56% | 2,988,571 | 1.14B |
| 234 | VERA | Vera Therapeutics, Inc. | 2.38B | -8.85% | 2,018,424 | - |
| 235 | MLYS | Mineralys Therapeutics, Inc. | 2.38B | -8.54% | 1,479,340 | - |
| 236 | NEO | NeoGenomics, Inc. | 2.36B | -2.81% | 2,911,644 | 766.30M |
| 237 | HRMY | Harmony Biosciences Holdings, Inc. | 2.36B | -2.53% | 1,080,688 | 959.90M |
| 238 | SLS | SELLAS Life Sciences Group, Inc. | 2.33B | -4.16% | 3,888,917 | - |
| 239 | PHVS | Pharvaris N.V. | 2.32B | -6.05% | 654,160 | - |
| 240 | ALMR | Alamar Biosciences, Inc. | 2.23B | -3.25% | 353,006 | 100.42M |
| 241 | UFPT | UFP Technologies, Inc. | 2.23B | 0.76% | 83,307 | 631.64M |
| 242 | OCUL | Ocular Therapeutix, Inc. | 2.20B | -4.76% | 2,089,351 | 52.06M |
| 243 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.19B | -2.39% | 4,466,749 | 940.61M |
| 244 | SDGR | Schrödinger, Inc. | 2.19B | -4.79% | 3,066,550 | 259.04M |
| 245 | AUPH | Aurinia Pharmaceuticals Inc. | 2.18B | -1.56% | 787,412 | 311.51M |
| 246 | PBH | Prestige Consumer Healthcare Inc. | 2.18B | -3.79% | 503,962 | 1.10B |
| 247 | ADMA | ADMA Biologics, Inc. | 2.17B | -1.12% | 2,595,708 | 512.28M |
| 248 | PVLA | Palvella Therapeutics, Inc. | 2.15B | -5.42% | 180,598 | - |
| 249 | BHC | Bausch Health Companies Inc. | 2.14B | -1.72% | 1,818,009 | 10.85B |
| 250 | GENB | Generate Biomedicines, Inc. | 2.12B | -5.38% | 1,426,008 | 26.48M |
| 251 | ADUS | Addus HomeCare Corporation | 2.10B | 0.60% | 209,190 | 1.48B |
| 252 | ALVO | Alvotech | 2.07B | -0.51% | 774,257 | 494.61M |
| 253 | BHVN | Biohaven Ltd. | 2.06B | -7.95% | 2,742,903 | - |
| 254 | TRVI | Trevi Therapeutics, Inc. | 2.06B | -5.12% | 1,349,815 | - |
| 255 | MD | Pediatrix Medical Group, Inc. | 2.05B | -1.86% | 454,088 | 1.95B |
| 256 | LKFT | Lakefront Biotherapeutics NV | 2.04B | 1.76% | 636,671 | 1.13B |
| 257 | AGIO | Agios Pharmaceuticals, Inc. | 2.04B | -2.23% | 752,476 | 98.34M |
| 258 | URGN | UroGen Pharma Ltd. | 2.03B | -2.64% | 1,298,452 | 188.73M |
| 259 | ESTA | Establishment Labs Holdings Inc. | 2.02B | -3.53% | 319,171 | 245.82M |
| 260 | NUVB | Nuvation Bio Inc. | 2.00B | -6.39% | 4,606,056 | 169.90M |
| 261 | SRPT | Sarepta Therapeutics, Inc. | 2.00B | -8.94% | 3,757,657 | 1.97B |
| 262 | INSP | Inspire Medical Systems, Inc. | 2.00B | -3.14% | 729,567 | 898.74M |
| 263 | MESO | Mesoblast Limited | 1.99B | -3.96% | 451,522 | 120.25M |
| 264 | VCEL | Vericel Corporation | 1.99B | -3.56% | 433,947 | 306.30M |
| 265 | RXRX | Recursion Pharmaceuticals, Inc. | 1.98B | -8.64% | 23,669,417 | 54.86M |
| 266 | PGNY | Progyny, Inc. | 1.98B | -1.56% | 1,347,371 | 1.31B |
| 267 | KOD | Kodiak Sciences Inc. | 1.98B | -6.75% | 1,053,135 | - |
| 268 | NKTR | Nektar Therapeutics | 1.97B | -5.43% | 1,843,759 | 54.59M |
| 269 | ZYME | Zymeworks Inc. | 1.95B | -0.25% | 647,792 | 37.13M |
| 270 | XRAY | DENTSPLY SIRONA Inc. | 1.95B | -1.71% | 3,351,939 | 3.64B |
| 271 | ZBIO | Zenas BioPharma, Inc. | 1.93B | -10.35% | 525,074 | 1.00M |
| 272 | PRGO | Perrigo Company plc | 1.92B | -3.28% | 1,455,764 | 4.14B |
| 273 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.91B | -1.21% | 1,549,895 | 208.78M |
| 274 | CMPS | COMPASS Pathways plc | 1.90B | -6.97% | 2,578,297 | - |
| 275 | NVCR | NovoCure Limited | 1.89B | -2.52% | 777,830 | 699.19M |
| 276 | SGRY | Surgery Partners, Inc. | 1.89B | -7.85% | 3,723,617 | 3.37B |
| 277 | VIR | Vir Biotechnology, Inc. | 1.88B | -3.57% | 1,685,268 | 303.23M |
| 278 | FTRE | Fortrea Holdings Inc. | 1.86B | -4.45% | 1,067,374 | 2.68B |
| 279 | BLFS | BioLife Solutions, Inc. | 1.85B | -0.87% | 929,661 | 106.69M |
| 280 | LMAT | LeMaitre Vascular, Inc. | 1.84B | -0.49% | 247,098 | 262.43M |
| 281 | XNCR | Xencor, Inc. | 1.80B | -3.58% | 1,156,588 | 104.97M |
| 282 | SEPN | Septerna, Inc. | 1.79B | -4.78% | 509,744 | 98.88M |
| 283 | SNDA | Sonida Senior Living, Inc. | 1.79B | -0.92% | 571,832 | 481.07M |
| 284 | GHRS | GH Research PLC | 1.78B | -6.82% | 178,779 | - |
| 285 | ASTH | Astrana Health, Inc. | 1.76B | -2.25% | 405,175 | 3.84B |
| 286 | NBTX | Nanobiotix S.A. | 1.75B | 1.08% | 126,950 | 38.27M |
| 287 | PSNL | Personalis, Inc. | 1.75B | -0.06% | 1,123,841 | 69.67M |
| 288 | NVAX | Novavax, Inc. | 1.74B | -2.59% | 5,773,223 | 413.80M |
| 289 | NTLA | Intellia Therapeutics, Inc. | 1.73B | -2.84% | 5,042,163 | 59.51M |
| 290 | COAG | Hemab Therapeutics Holdings, Inc. | 1.72B | -3.97% | 417,069 | - |
| 291 | KLRA | Kailera Therapeutics, Inc. | 1.70B | 2.66% | 1,631,805 | - |
| 292 | FRNM | Freenome, Inc. | 1.69B | -4.62% | 578,478 | 35.41M |
| 293 | STOK | Stoke Therapeutics, Inc. | 1.68B | -10.58% | 1,201,656 | 27.59M |
| 294 | ABSI | Absci Corporation | 1.67B | -9.01% | 4,721,170 | 1.56M |
| 295 | RAPP | Rapport Therapeutics, Inc. | 1.64B | -17.70% | 745,581 | 20.00M |
| 296 | ALHC | Alignment Healthcare, Inc. | 1.63B | -1.63% | 13,721,989 | 4.58B |
| 297 | IMCR | Immunocore Holdings plc | 1.62B | -2.71% | 411,737 | 430.78M |
| 298 | TSHA | Taysha Gene Therapies, Inc. | 1.60B | -4.84% | 5,507,255 | 5.49M |
| 299 | TYRA | Tyra Biosciences, Inc. | 1.60B | -9.15% | 1,102,754 | - |
| 300 | ANIP | ANI Pharmaceuticals, Inc. | 1.59B | -4.47% | 433,642 | 978.38M |
| 301 | ETON | Eton Pharmaceuticals, Inc. | 1.59B | -2.59% | 436,113 | 105.60M |
| 302 | XERS | Xeris Biopharma Holdings, Inc. | 1.58B | -0.80% | 2,042,953 | 335.41M |
| 303 | SNDX | Syndax Pharmaceuticals, Inc. | 1.58B | -3.02% | 2,086,471 | 252.25M |
| 304 | MAZE | Maze Therapeutics, Inc. | 1.56B | -1.02% | 1,704,071 | 20.00M |
| 305 | ATEC | Alphatec Holdings, Inc. | 1.55B | -2.90% | 1,629,749 | 815.05M |
| 306 | KMTS | Kestra Medical Technologies, Ltd. | 1.52B | -2.03% | 222,753 | 106.73M |
| 307 | ANAB | AnaptysBio, Inc. | 1.52B | -5.84% | 779,606 | 106.09M |
| 308 | OMCL | Omnicell, Inc. | 1.50B | -0.54% | 437,052 | 1.25B |
| 309 | OMER | Omeros Corporation | 1.50B | -1.47% | 1,349,356 | 38.42M |
| 310 | ARDT | Ardent Health, Inc. | 1.50B | -2.83% | 427,227 | 6.41B |
| 311 | AZTA | Azenta, Inc. | 1.49B | -0.55% | 738,252 | 613.81M |
| 312 | AVBP | ArriVent BioPharma, Inc. | 1.49B | -0.26% | 1,206,018 | - |
| 313 | INBX | Inhibrx Biosciences, Inc. | 1.48B | -9.34% | 375,105 | 1.30M |
| 314 | KRSA | Korsana Biosciences, Inc. | 1.47B | -7.66% | 66,327 | - |
| 315 | RARE | Ultragenyx Pharmaceutical Inc. | 1.46B | -4.74% | 5,712,615 | 717.00M |
| 316 | INVA | Innoviva, Inc. | 1.46B | -3.53% | 4,031,222 | 440.00M |
| 317 | HCSG | Healthcare Services Group, Inc. | 1.46B | -1.48% | 567,183 | 1.86B |
| 318 | AAPG | Ascentage Pharma Group International | 1.45B | -1.83% | 1,460 | 94.61M |
| 319 | AGL | agilon health, inc. | 1.42B | -2.63% | 211,927 | 5.92B |
| 320 | PNTG | The Pennant Group, Inc. | 1.38B | 0.61% | 269,181 | 1.10B |
| 321 | PAHC | Phibro Animal Health Corporation | 1.38B | -2.99% | 141,687 | 1.52B |
| 322 | NUTX | Nutex Health Inc. | 1.38B | -3.33% | 109,650 | 846.72M |
| 323 | ORIC | ORIC Pharmaceuticals, Inc. | 1.38B | -1.26% | 1,717,560 | - |
| 324 | BRVE | Braveheart Bio, Inc. | 1.38B | -9.11% | 521,745 | - |
| 325 | CNMD | CONMED Corporation | 1.37B | -0.80% | 491,190 | 1.37B |
| 326 | KARD | Kardigan, Inc. | 1.36B | -11.68% | 654,229 | - |
| 327 | BCAX | Bicara Therapeutics Inc. | 1.36B | -10.07% | 954,718 | - |
| 328 | DRTS | Alpha Tau Medical Ltd. | 1.34B | -4.10% | 727,069 | - |
| 329 | LTGO | Latigo Biotherapeutics, Inc. | 1.32B | -4.08% | 214,609 | - |
| 330 | CERT | Certara, Inc. | 1.32B | -2.15% | 2,585,970 | 421.75M |
| 331 | AVLN | Avalyn Pharma Inc. | 1.32B | -8.57% | 252,042 | - |
| 332 | AMN | AMN Healthcare Services, Inc. | 1.31B | -1.82% | 347,510 | 3.43B |
| 333 | TRAX | First Tracks Biotherapeutics, Inc. | 1.31B | -10.65% | 659,458 | - |
| 334 | SVRA | Savara Inc. | 1.27B | -5.66% | 3,353,902 | - |
| 335 | OPK | OPKO Health, Inc. | 1.27B | -1.73% | 1,783,717 | 587.90M |
| 336 | OMDA | Omada Health, Inc. | 1.27B | -3.18% | 713,083 | 309.76M |
| 337 | LBRX | LB Pharmaceuticals Inc | 1.26B | -8.20% | 481,679 | - |
| 338 | DMRA | Damora Therapeutics, Inc. | 1.26B | -8.79% | 1,067,227 | - |
| 339 | HROW | Harrow, Inc. | 1.26B | -2.47% | 347,957 | 275.59M |
| 340 | CRON | Cronos Group Inc. | 1.26B | -0.87% | 511,096 | 179.09M |
| 341 | USPH | U.S. Physical Therapy, Inc. | 1.23B | -0.63% | 133,198 | 804.27M |
| 342 | INNV | InnovAge Holding Corp. | 1.23B | -15.53% | 6,584,750 | 989.71M |
| 343 | REPL | Replimune Group, Inc. | 1.22B | -3.79% | 1,887,461 | - |
| 344 | IART | Integra LifeSciences Holdings Corporation | 1.21B | -3.06% | 573,083 | 1.65B |
| 345 | IMTX | Immatics N.V. | 1.18B | -3.04% | 384,168 | 47.65M |
| 346 | BBNX | Beta Bionics, Inc. | 1.17B | -2.72% | 1,396,266 | 119.01M |
| 347 | AORT | Artivion, Inc. | 1.15B | -2.49% | 504,204 | 471.47M |
| 348 | VOR | Vor Biopharma Inc. | 1.15B | -11.95% | 2,764,310 | - |
| 349 | BVS | Bioventus Inc. | 1.14B | -0.29% | 329,606 | 581.85M |
| 350 | SPTX | Seaport Therapeutics, Inc. | 1.14B | -4.78% | 179,279 | - |
| 351 | TNDM | Tandem Diabetes Care, Inc. | 1.14B | -6.40% | 2,806,711 | 1.04B |
| 352 | GDRX | GoodRx Holdings, Inc. | 1.13B | -3.49% | 849,094 | 785.23M |
| 353 | MGTX | MeiraGTx Holdings plc | 1.13B | -4.86% | 1,419,037 | 397.50M |
| 354 | TDOC | Teladoc Health, Inc. | 1.11B | -3.46% | 2,967,210 | 2.49B |
| 355 | IRMD | IRADIMED CORPORATION | 1.10B | -0.13% | 164,112 | 86.34M |
| 356 | MLTX | MoonLake Immunotherapeutics | 1.10B | -3.59% | 2,003,315 | - |
| 357 | AKTS | Aktis Oncology, Inc. | 1.10B | -10.81% | 589,166 | 10.06M |
| 358 | CGEM | Cullinan Therapeutics, Inc. | 1.09B | -22.15% | 2,596,061 | - |
| 359 | ANRO | Alto Neuroscience, Inc. | 1.08B | -10.66% | 639,880 | - |
| 360 | MNKD | MannKind Corporation | 1.07B | -4.30% | 2,877,353 | 393.63M |
| 361 | CSTL | Castle Biosciences, Inc. | 1.07B | 0.14% | 348,305 | 357.28M |
| 362 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.06B | 2.63% | 508,095 | 730.02M |
| 363 | CRVS | Corvus Pharmaceuticals, Inc. | 1.05B | -6.70% | 946,627 | - |
| 364 | ENOV | Enovis Corporation | 1.05B | -0.82% | 1,180,013 | 2.30B |
| 365 | PRCT | PROCEPT BioRobotics Corporation | 1.04B | -1.84% | 914,635 | 337.34M |
| 366 | GLUE | Monte Rosa Therapeutics, Inc. | 1.01B | -5.63% | 1,175,811 | 28.73M |
| 367 | ANL | Adlai Nortye Group Ltd. | 1.01B | -5.12% | 218,129 | 18.06M |
| 368 | JANX | Janux Therapeutics, Inc. | 1.01B | -5.44% | 967,514 | 24.00M |
| 369 | ODTX | Odyssey Therapeutics, Inc. | 994.79M | -11.05% | 255,190 | 99.00K |
| 370 | STAA | STAAR Surgical Company | 992.85M | -4.12% | 846,686 | 339.59M |
| 371 | KURA | Kura Oncology, Inc. | 982.13M | -5.88% | 2,771,764 | 77.23M |
| 372 | PCRX | Pacira BioSciences, Inc. | 981.80M | -0.28% | 450,691 | 746.16M |
| 373 | LMRI | Lumexa Imaging Holdings, Inc. | 976.12M | -3.42% | 980,981 | 1.04B |
| 374 | ALMS | Alumis Inc. | 963.00M | -8.26% | 2,694,887 | 7.40M |
| 375 | ABUS | Arbutus Biopharma Corporation | 959.56M | -3.19% | 10,841,707 | 181.72M |
| 376 | HELP | Cybin Inc. | 951.24M | -5.03% | 1,850,235 | - |
| 377 | SLBT | SL Science Holding Limited | 946.64M | -1.19% | 30,686 | 3.27M |
| 378 | OBX | Obsidian Therapeutics, Inc. | 942.65M | -10.24% | 582,606 | - |
| 379 | SGP | SpyGlass Pharma, Inc. | 941.90M | -1.85% | 149,299 | - |
| 380 | APMD | Apnimed, Inc. | 936.28M | -11.84% | 858,037 | 115.12M |
| 381 | JBIO | Jade Biosciences, Inc. | 935.52M | -12.23% | 1,464,553 | - |
| 382 | SANA | Sana Biotechnology, Inc. | 922.03M | -7.51% | 3,840,270 | - |
| 383 | LXRX | Lexicon Pharmaceuticals, Inc. | 916.61M | -5.50% | 3,172,478 | 41.47M |
| 384 | CBLL | CeriBell, Inc. | 906.49M | -2.60% | 353,834 | 101.96M |
| 385 | RIGL | Rigel Pharmaceuticals, Inc. | 899.06M | -1.41% | 151,375 | 276.79M |
| 386 | TBPH | Theravance Biopharma, Inc. | 884.18M | - | 10,043,491 | 104.31M |
| 387 | HSTM | HealthStream, Inc. | 879.94M | -0.86% | 143,504 | 321.12M |
| 388 | ARDX | Ardelyx, Inc. | 867.17M | -3.87% | 6,279,784 | 450.89M |
| 389 | CADL | Candel Therapeutics, Inc. | 863.89M | -4.73% | 1,284,812 | - |
| 390 | SLDB | Solid Biosciences Inc. | 859.95M | -10.09% | 1,088,216 | - |
| 391 | GMRS | GMR Solutions Inc. | 854.94M | -2.74% | 813,727 | 5.88B |
| 392 | IMMX | Immix Biopharma, Inc. | 852.75M | -7.09% | 1,168,276 | - |
| 393 | ATTO | Attovia Therapeutics, Inc. | 851.40M | -10.47% | 689,036 | 1.80M |
| 394 | SIBN | SI-BONE, Inc. | 834.52M | -1.01% | 514,723 | 213.60M |
| 395 | FDMT | 4D Molecular Therapeutics, Inc. | 827.56M | -5.67% | 1,465,454 | 92.01M |
| 396 | AVTX | Avalo Therapeutics, Inc. | 820.54M | -7.33% | 1,111,198 | 59.00K |
| 397 | INMD | InMode Ltd. | 815.65M | -1.80% | 381,804 | 374.63M |
| 398 | FTH | Faeth Therapeutics, Inc. | 815.27M | -5.54% | 435,047 | - |
| 399 | IVA | Inventiva S.A. | 807.61M | -5.48% | 2,133,042 | 7.94M |
| 400 | ACHV | Achieve Life Sciences, Inc. | 805.73M | -3.57% | 1,328,039 | - |
| 401 | GERN | Geron Corporation | 796.67M | -5.34% | 10,925,132 | 204.56M |
| 402 | ETRA | Electra Therapeutics, Inc. | 795.26M | -6.98% | 875,385 | - |
| 403 | GYRE | Gyre Therapeutics, Inc. | 784.65M | -1.20% | 164,558 | 109.82M |
| 404 | WVE | Wave Life Sciences, Inc. | 778.34M | -9.20% | 3,975,017 | 65.37M |
| 405 | VREX | Varex Imaging Corporation | 777.63M | -0.16% | 388,604 | 865.00M |
| 406 | ACRS | Aclaris Therapeutics, Inc. | 774.27M | -8.04% | 1,962,934 | 8.22M |
| 407 | DSGN | Design Therapeutics, Inc. | 773.51M | -6.08% | 738,217 | - |
| 408 | OLMA | Olema Pharmaceuticals, Inc. | 772.60M | -8.40% | 1,642,239 | - |
| 409 | AHCO | AdaptHealth Corp. | 760.43M | -1.21% | 1,986,616 | 3.36B |
| 410 | PHAR | Pharming Group N.V. | 758.99M | -4.35% | 28,596 | 366.48M |
| 411 | AVR | Anteris Technologies Global Corp. | 742.63M | -6.27% | 868,853 | 2.24M |
| 412 | VSTM | Verastem, Inc. | 740.81M | -2.27% | 1,936,674 | 87.53M |
| 413 | GLAS | Glass House Brands Inc. | 739.80M | -2.00% | 884,471 | 176.98M |
| 414 | CTKB | Cytek Biosciences, Inc. | 738.30M | -0.53% | 1,261,298 | 206.71M |
| 415 | DBVT | DBV Technologies S.A. | 735.66M | -3.76% | 377,512 | 5.04M |
| 416 | ANNX | Annexon, Inc. | 733.67M | -7.42% | 2,423,554 | - |
| 417 | COLL | Collegium Pharmaceutical, Inc. | 730.87M | -1.45% | 878,439 | 808.21M |
| 418 | CLYM | Climb Bio, Inc. | 719.10M | -11.89% | 2,141,771 | - |
| 419 | BLSM | BlossomHill Therapeutics, Inc. | 710.07M | -11.52% | 219,570 | - |
| 420 | QDEL | QuidelOrtho Corporation | 709.07M | -5.48% | 1,114,675 | 2.67B |
| 421 | IRWD | Ironwood Pharmaceuticals, Inc. | 705.57M | -5.64% | 1,657,279 | 389.32M |
| 422 | OABI | OmniAb, Inc. | 696.42M | -2.64% | 1,051,021 | 38.46M |
| 423 | MDXG | MiMedx Group, Inc. | 695.28M | -3.25% | 1,003,392 | 355.17M |
| 424 | STLN | Starling Oncology, Inc. | 695.07M | -3.26% | 1,115,358 | 587.24M |
| 425 | SLN | Silence Therapeutics plc | 693.01M | -6.35% | 876,992 | 615.00K |
| 426 | SOPH | SOPHiA GENETICS SA | 687.83M | 0.12% | 563,013 | 86.17M |
| 427 | NVCT | Nuvectis Pharma, Inc. | 686.49M | -8.39% | 169,188 | - |
| 428 | ZVRA | Zevra Therapeutics, Inc. | 672.22M | -2.25% | 735,882 | 136.07M |
| 429 | AHG | Akso Health Group | 659.58M | 4.03% | 3,863 | 13.83M |
| 430 | SGMT | Sagimet Biosciences Inc. | 647.69M | -6.04% | 1,115,880 | - |
| 431 | ANGO | AngioDynamics, Inc. | 641.07M | -1.02% | 503,398 | 320.17M |
| 432 | STTK | Shattuck Labs, Inc. | 638.31M | -2.15% | 1,386,538 | 1.00M |
| 433 | AURA | Aura Biosciences, Inc. | 624.30M | -6.67% | 1,037,162 | - |
| 434 | SSII | SS Innovations International, Inc. | 623.20M | -5.76% | 76,375 | 52.40M |
| 435 | ALT | Altimmune, Inc. | 620.51M | -6.45% | 4,531,546 | 31.00K |
| 436 | NGNE | Neurogene Inc. | 618.95M | -7.95% | 276,187 | 925.00K |
| 437 | OCS | Oculis Holding AG | 616.70M | -6.72% | 143,772 | 1.45M |
| 438 | CBIO | Crescent Biopharma, Inc. | 607.35M | -13.69% | 727,664 | 11.88M |
| 439 | CTMX | CytomX Therapeutics, Inc. | 605.76M | -5.44% | 4,955,454 | 18.30M |
| 440 | VALN | Valneva SE | 601.98M | -3.64% | 14,685 | 163.30M |
| 441 | PHR | Phreesia, Inc. | 600.85M | -4.16% | 756,921 | 507.79M |
| 442 | MNPR | Monopar Therapeutics Inc. | 599.93M | -7.50% | 89,326 | - |
| 443 | CRMD | CorMedix Inc. | 599.39M | -1.16% | 812,569 | 462.25M |
| 444 | MPLT | MapLight Therapeutics, Inc. | 598.55M | -0.83% | 537,296 | - |
| 445 | AQST | Aquestive Therapeutics, Inc. | 589.90M | -5.05% | 1,951,991 | 54.09M |
| 446 | WEAV | Weave Communications, Inc. | 588.79M | 0.27% | 886,946 | 257.79M |
| 447 | FLGT | Fulgent Genetics, Inc. | 585.25M | -1.76% | 190,336 | 323.93M |
| 448 | KIDS | OrthoPediatrics Corp. | 583.03M | -1.89% | 99,038 | 252.72M |
| 449 | DNA | Ginkgo Bioworks Holdings, Inc. | 577.78M | -8.43% | 1,844,385 | 132.42M |
| 450 | ALLO | Allogene Therapeutics, Inc. | 576.97M | -2.34% | 5,965,945 | 4.64M |
| 451 | DRUG | Bright Minds Biosciences Inc. | 570.62M | -4.53% | 90,375 | - |
| 452 | EVO | Evotec SE | 567.05M | -2.85% | 37,236 | 819.47M |
| 453 | TLRY | Tilray Brands, Inc. | 563.04M | -2.84% | 2,857,968 | 915.45M |
| 454 | PRME | Prime Medicine, Inc. | 556.84M | -11.58% | 3,333,888 | 4.07M |
| 455 | PHAT | Phathom Pharmaceuticals, Inc. | 554.82M | -9.99% | 1,045,097 | 239.66M |
| 456 | DCTH | Delcath Systems, Inc. | 553.79M | -2.68% | 279,454 | 95.42M |
| 457 | BWAY | BrainsWay Ltd. | 549.29M | -1.32% | 90,426 | 60.70M |
| 458 | EPRX | Eupraxia Pharmaceuticals Inc. | 535.37M | -5.13% | 662,592 | - |
| 459 | EOLS | Evolus, Inc. | 528.40M | -3.03% | 415,972 | 316.49M |
| 460 | SENS | Senseonics Holdings, Inc. | 527.42M | -0.84% | 840,124 | 48.55M |
| 461 | AGMB | AgomAb Therapeutics NV | 524.00M | -7.40% | 98,686 | - |
| 462 | CERS | Cerus Corporation | 523.96M | -2.62% | 1,635,682 | 221.55M |
| 463 | AUTL | Autolus Therapeutics plc | 519.02M | -3.94% | 1,442,554 | 117.39M |
| 464 | ARVN | Arvinas, Inc. | 511.97M | -7.99% | 761,421 | 316.70M |
| 465 | TCMD | Tactile Systems Technology, Inc. | 508.09M | -1.10% | 140,842 | 350.31M |
| 466 | KMDA | Kamada Ltd. | 506.85M | -1.13% | 138,715 | 191.85M |
| 467 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 4.81M |
| 468 | CAPR | Capricor Therapeutics, Inc. | 504.07M | -7.17% | 3,147,288 | 11.13M |
| 469 | INDP | Indaptus Therapeutics, Inc. | 502.32M | -5.51% | 624,662 | - |
| 470 | SCTX | Scribe Therapeutics Inc. | 502.26M | -5.49% | 532,600 | 33.30M |
| 471 | OVID | Ovid Therapeutics Inc. | 501.92M | -6.88% | 2,635,313 | 1.58M |
| 472 | PROK | ProKidney Corp. | 498.83M | -9.84% | 1,440,748 | 818.00K |
| 473 | RGNX | REGENXBIO Inc. | 495.10M | -7.98% | 1,113,281 | 174.48M |
| 474 | TECX | Tectonic Therapeutic, Inc. | 488.34M | -5.74% | 207,422 | - |
| 475 | ASMB | Assembly Biosciences, Inc. | 488.04M | -5.82% | 275,239 | 74.85M |
| 476 | NPCE | NeuroPace, Inc. | 487.75M | -3.40% | 166,375 | 106.99M |
| 477 | ENTX | Entera Bio Ltd. | 486.53M | -5.70% | 857,940 | 42.00K |
| 478 | TKNO | Alpha Teknova, Inc. | 479.44M | 1.82% | 381,591 | 43.70M |
| 479 | PBYI | Puma Biotechnology, Inc. | 479.03M | -5.50% | 475,973 | 231.24M |
| 480 | NRC | NRC Health | 477.12M | -1.33% | 105,985 | 140.00M |
| 481 | SRTA | Strata Critical Medical, Inc. | 475.95M | -1.82% | 895,529 | 255.98M |
| 482 | CTNM | Contineum Therapeutics, Inc. | 470.64M | -6.64% | 550,281 | - |
| 483 | SGHT | Sight Sciences, Inc. | 468.25M | -1.05% | 217,831 | 83.38M |
| 484 | CLPT | ClearPoint Neuro, Inc. | 456.65M | -5.19% | 579,190 | 42.28M |
| 485 | MASS | 908 Devices Inc. | 452.40M | -2.10% | 243,069 | 60.84M |
| 486 | PRTA | Prothena Corporation plc | 445.60M | -3.45% | 357,843 | 54.53M |
| 487 | PRLD | Prelude Therapeutics Incorporated | 443.91M | -11.13% | 704,958 | 22.42M |
| 488 | EIKN | Eikon Therapeutics, Inc. | 440.36M | -9.47% | 727,437 | - |
| 489 | PACB | Pacific Biosciences of California, Inc. | 438.27M | -4.08% | 5,257,289 | 159.27M |
| 490 | KYTX | Kyverna Therapeutics, Inc. | 437.23M | -5.86% | 1,032,138 | - |
| 491 | CTEV | Claritev Corporation | 424.36M | -14.97% | 174,294 | 994.67M |
| 492 | AVIR | Atea Pharmaceuticals, Inc. | 423.48M | -6.38% | 232,335 | - |
| 493 | RZLT | Rezolute, Inc. | 417.87M | -0.99% | 1,683,226 | - |
| 494 | SPRY | ARS Pharmaceuticals, Inc. | 415.69M | -6.70% | 1,370,304 | 116.93M |
| 495 | ZURA | Zura Bio Limited | 414.94M | -3.99% | 2,062,445 | - |
| 496 | EDIT | Editas Medicine, Inc. | 413.13M | -7.88% | 5,166,778 | 47.01M |
| 497 | EVH | Evolent Health, Inc. | 409.27M | -4.74% | 1,013,535 | 2.10B |
| 498 | GALT | Galectin Therapeutics Inc. | 408.44M | -2.17% | 174,119 | - |
| 499 | CYH | Community Health Systems, Inc. | 407.94M | -0.33% | 996,946 | 11.98B |
| 500 | DMAC | DiaMedica Therapeutics Inc. | 407.68M | -2.83% | 174,141 | - |